Welcome guest, Login | Register

Home

X
加载中

Eosinophils are multifunctional effector cells implicated in the pathogenesis of a variety of diseases including asthma, eosinophil gastrointestinal disorders and helminth infection. Mouse bone marrow derived progenitor cells can be differentiated into eosinophils following IL-5 exposure. These bone marrow derived eosinophils are fully differentiated at the end of a 14 day culture based on morphology and expression of molecular markers.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Bone Marrow Derived Eosinophil Cultures

Immunology > Immune cell isolation > Maintenance and differentiation
Authors: Thomas X. Lu
Thomas X. LuAffiliation: Division of Pediatrics, Cincinnati Children's Hospital Medical Center / University of Cincinnati, Cincinnati, USA
Bio-protocol author page: a1440
 and Marc E. Rothenberg
Marc E. RothenbergAffiliation: Division of Pediatrics, Cincinnati Children's Hospital Medical Center / University of Cincinnati, Cincinnati, USA
For correspondence: marc.rothenberg@cchmc.org
Bio-protocol author page: a1441
Vol 4, Iss 12, 6/20/2014, 2791 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1161

[Abstract] Eosinophils are multifunctional effector cells implicated in the pathogenesis of a variety of diseases including asthma, eosinophil gastrointestinal disorders and helminth infection. Mouse bone marrow derived progenitor cells can be differentiated into eosinophils following IL-5 exposure. These bone marrow derived eosinophils are fully differentiated at the end of a 14 day culture based on morphology and expression of molecular markers.

Materials and Reagents

  1. Mice
  2. Histopaque 1083 (Sigma-Aldrich, catalog number: 10831-100ml)
  3. IMDM with Glutamax-I (Life Technologies, InvitrogenTM, catalog number: 31980-097)
  4. Fetal Bovine Serum (FBS) (Atlanta Biologicals, catalog number: S11150)
  5. Penicillin/Streptomycin (Life Technologies, InvitrogenTM, catalog number: 15140-122)
  6. Stem Cell Factor (Pepro tech, catalog number: 250-03)
  7. FLT-3 Ligand (Pepro tech, catalog number: 250-31L)
  8. Recombinant mouse IL-5 (Pepro tech, catalog number: 215-15)
  9. PBS (Life Technologies, InvitrogenTM, catalog number: 14200-166)
  10. Diff-Quick Stain Kit (Thermo Fisher Scientific, catalog numbers: 23-122-929, 23-122-952, and 23-122-937)
  11. RBC lysis buffer (Sigma-Aldrich, catalog number: R7757-100ml)
  12. CCR3 (R&D systems, Catalog number: FAB729F)
  13. Siglec-F (BD, PharmingenTM, Catalog number: 552126)
  14. IMDM cell culture media (see Recipes)

Equipment

  1. 6-well tissue culture plate
  2. Dissection tools: scalpel, scissors
  3. 1 ml syringe
  4. 15 ml sterile centrifuge tube
  5. Centrifuge
  6. 37 °C, 5% CO2 cell culture incubator
  7. Microscope
  8. Hemocytometer

Procedure

  1. Collect femur/tibia from 6-8 mice.
    Note: Mice between 6-8 weeks old will give the highest yield of low-density bone marrow fraction.
  2. Flush the bone marrow from femur/tibia with PBS, pipet up and down to break up the bone marrow into single cell suspension.
  3. Spin down the cells at 300 x g 8 min at 4 °C.
  4. Resuspend cells in 15 ml of RBC lysis buffer, incubate for 2 min at 37 °C.
    Note: If less than 6-8 mice were used, there is no need to adjust the volume of RBC lysis buffer. If more than 6-8 mice were used, we recommend scaling up the RBC lysis buffer accordingly and also scaling up the amount of PBS used to neutralize the RBC lysis buffer in step 5.
  5. Add 30 ml of PBS to neutralize the RBC lysis buffer.
  6. Spin down the cells at 300 x g 8 min at 4 °C.
  7. Resuspend the cells in 16 ml of PBS.
  8. Add 4 ml of histopaque 1083 to each of 15 ml centrifuge tube.
  9. Carefully layer 4 ml of cells from step 7 to 4 ml of histopage 1083 prepared in step 8. Must use very slow speed to ensure that the layers are not disturbed. At the end of this step, there should be two layers: bottom clear layer contains histopage 1083, and top cloudy layer contaning cells.
  10. Centrifuge at 400 x g for exactly 30 min at room temperature. The brake on the centrifuge needs to be in the off position.
  11. Collect the low density fraction with a 1 ml micropipette. The low density fraction is at the interface between upper and lower layers. The approximate volume of this fraction is 0.5 ml to 1 ml.
    Note: The low-density fraction is cloudy due to the low-density bone marrow cells at this fraction. The upper layer immediately above it is clear. The lower layer immediately below it should be significantly less cloudy compared to the low-density fraction.
  12. Wash the cells with 30 ml of PBS and spin down at 300 x g 8 min.
  13. Resusped the cells in IMDM with Glutamax-1 with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin supplemented with 100 ng/ml stem cell factor and 100 ng/ml FLT-3 ligand at a concentration of 1 x 106/ml.
  14. Plate 3 x 106 cells per well in 6 well plates (3 ml).
  15. Change culture media on day 2 by aspirating 1.5 ml of media from each well and adding 1.5 ml of new media (see Recipes).
    Note: Be careful not to aspirate the cells as the cells are settled to the bottom of the plate but are not attached.
  16. On day 4 , collect all the cells, spin down the cells at 300 x g 8 min at 4 °C, wash once with 30 ml of PBS, then resuspend the cells at a concentration of 1 x 106/ml in IMDM with Glutamax-1 with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin supplemented with 10 ng/ml of IL-5.
  17. Change the culture culture media every other day. Cells should be counted and concentration adjusted to 1 x 106/ml during each media change.
  18. At day 14, collect mature eosinophils for further studies. Eosinophil maturity can be assessed by FACS staining for CCR3 and Siglec-F and/or Diff-Quik staining of cytospin preparations following the manufacturer’s protocol (Figure 1).


    Figure 1. Morphology of mature bone marrow derived eosinophils. Morphology determined by Diff-Quik staining following the manufacturer’s protocol.

Recipes

  1. IMDM cell culture media
    IMDM with Glutamax-1
    10% FBS
    100 U/ml penicillin
    100 μg/ml streptomycin supplemented with 100 ng/ml stem cell factor
    100 ng/ml FLT-3 ligand
    Cellular concentration of 1 x 106/ml

Acknowledgments

This protocol has been adapted from Lu et al. (2013).

References

  1. Lu, T. X., Lim, E. J., Besse, J. A., Itskovich, S., Plassard, A. J., Fulkerson, P. C., Aronow, B. J. and Rothenberg, M. E. (2013). MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol 190(4):1576-1582.


How to cite this protocol: Lu, T. X. and Rothenberg, M. E. (2014). Bone Marrow Derived Eosinophil Cultures. Bio-protocol 4(12): e1161. DOI: 10.21769/BioProtoc.1161; Full Text



Reproducibility Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook